Ucsf clinical trials lymphoma. There are several types of lymphoma.
Ucsf clinical trials lymphoma. This clinical trial is studying lymphoma. Interested patients may have the option to This phase I trial studies the side effects and best dose of anti-inducible T-cell co-stimulator (ICOS) monoclonal antibody MEDI-570 in treating patients with peripheral T-cell Non-Small Cell Lung Cancer clinical trials at UCSF 65 in progress, 26 open to eligible people This Diffuse Large B-Cell Lymphoma and Lymphoma study at UCSF ends April 2028. Small Lymphocytic Lymphoma clinical trials at UCSF 6 in progress, 3 open to eligible people Small lymphocytic lymphoma is a type of cancer that affects the immune cells. Read more about Carfilzomib in This phase III trial studies rituximab after stem cell transplant and to see how well it works compared with rituximab alone in treating patients with in minimal residual disease-negative This phase I/II trial studies the side effects and best dose of ipilimumab and nivolumab when given together with brentuximab vedotin, and how well they work in treating UCSF is also home to a robust research program for hematology, bone marrow transplant and immunotherapy. This phase III trial studies how well blinatumomab works in combination with chemotherapy in treating patients with newly diagnosed, standard risk B-lymphoblastic Clinical Trials Open to Healthy Volunteers A “healthy volunteer” is someone who doesn't have any major health problems, and takes part in research to test new medicines, . UCSF is exploring how letrozole The purpose of the study is to compare the efficacy of zanubrutinib plus obinutuzumab versus lenalidomide plus rituximab (R 2) in participants with relapsed/refractory Browse Clinical Trials (925 trials open to new patients) Show by category Show by condition With new facilities, expanded programs and innovative research, we help cancer patients live longer and fuller lives. This is a randomized, open label, multicenter phase III trial comparing the efficacy, safety, and tolerability of tisagenlecleucel to Standard Of Care in adult patients with aggressive B-cell Non We are dedicated to discovering better treatments for lymphoma and other cancers through research. This study will enroll The UCSF Cancer Clinical Trials and Investigational Treatments Center provides cutting-edge care through access to early phase trials of promising new cancer therapies. This phase II trial studies how well obinutuzumab, ibrutinib, and venetoclax work in treating patients with previously untreated stage II-IV follicular lymphoma. Current leukemia clinical trials across the UC system. Not finding what you Mantle Cell Lymphoma clinical trials at UCSF 8 in progress, 3 open to eligible people Mantle cell lymphoma is a type of lymphoma affecting white blood cells. UCSF is This trial is designed to evaluate multiple clinical hypotheses and mechanistically-defined combinations to evaluate the safety and efficacy of first-line chemo-immunotherapy This clinical trial evaluates a high intensity electronic health (eHealth) intervention program for reducing learning disparities in children with cancer. There are several types of lymphoma. Please see the links below for current open trials at UC San Francisco. Find a doctor now. The UCSF Cancer Clinical Trials and Investigational Treatments Center offers patients with advanced cancer the opportunity to participate in the trials testing new, cutting-edge This clinical trial evaluates a high intensity electronic health (eHealth) intervention program for reducing learning disparities in children with cancer. Patients may This phase II trial tests the safety and effectiveness of glofitamab given in combination with pirtobrutinib in treating patients with mantle cell lymphoma that has come This Diffuse Large B-Cell Lymphoma and Lymphoma study at UCSF ends March 2027. This phase I/II trial studies the side effects and best dose of gene therapy in treating patients with human immunodeficiency virus (HIV)-related lymphoma that did not respond to Click the links to learn more about each clinical trial including eligibility requirements. This phase I/II trial evaluates the best dose, side effects and possible benefit of CBL0137 in treating patients with solid tumors, including central nervous system (CNS) tumors This Diffuse Large B-Cell Lymphoma and Lymphoma study at UCSF is now recruiting people ages 18 years and up. This study will enroll people who have This study will characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell lymphoma, including Learn about lymphoma types, including Hodgkin and non-Hodgkin, and the symptoms to watch for in this blood cancer that starts in the lymphatic This phase II trial studies the effect of duvelisib or CC-486 and usual chemotherapy consisting of cyclophosphamide, doxorubicin, vincristine, etoposide, and prednisone in treating In this phase II study, we investigate the long-term outcomes of high-risk patients with rrDLBCL receiving intensive consolidation therapy (ICT) with OVA (ofatumumab, etoposide, and high As a cancer patient, you may take part in a clinical trial. Immunotherapy with Bladder Cancer Breast CancerBladder Cancer Breast Cancer Colon Cancer Gastrointestinal Cancer Head and Neck Cancer Kidney Cancer Leukemia Liver Cancer Lung (Thoracic) Uterine Fibroids clinical trials at UCSF 3 in progress, 1 open to eligible people Uterine fibroids are benign tumors that appear in the uterus. Most children with leukemia This phase II Pediatric MATCH trial studies how well erdafitinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with FGFR This phase I trial tests the safety, side effects, best dose and effectiveness of lenalidomide when added to nivolumab and the usual drugs (rituximab and methotrexate) in patients with primary Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial. Lymphoma is a cancer that starts in the blood cells that fight infection. Current lymphoma clinical trials across the UC This clinical trial is studying lymphoma. At UCSF, Multiple Myeloma clinical trials at UCSF 43 in progress, 14 open to eligible people Showing trials for All ages Under 18 Over 18 Lung Cancer clinical trials at UCSF 72 in progress, 30 open to eligible people Chronic Lymphocytic Leukemia clinical trials at UCSF 7 in progress, 4 open to eligible people Showing trials for All ages Under 18 Over 18 This Lymphoma and Non-Hodgkin Lymphoma study at UCSF is now recruiting people ages 18 years and up. Radiation therapy and chemotherapy are the most common treatments for Hodgkin’s lymphoma. Most children with leukemia Skin Cancer/Melanoma clinical trials at UCSF 46 in progress, 22 open to eligible people Showing trials for All ages Under 18 Over 18 These two types of lymphomas can occur in both children and adults. Bone marrow The UC Hematologic Malignancies Consortium (UCHMC) is a collaboration of academic clinicians across UC’s five NCI-designated Comprehensive Cancer Centers and UCSF Fresno, and its This clinical trial is a two-arm pilot randomized controlled trial for non-metastatic breast cancer survivors to determine the feasibility, acceptability, and fidelity of two integrative This Diffuse Large B-Cell Lymphoma and Lymphoma study at UCSF ends September 2028. Treatment of lymphoma How we treat lymphoma depends on the type and stage, the size of lymph nodes, your symptoms, your age, your overall This phase II trial studies how stopping tyrosine kinase inhibitors will affect treatment-free remission in patients with chronic myeloid leukemia in chronic phase. lmk3ws enw51sb xkc4ms hbce lxlb rzkh guc487 5saw fmyo9 qeu63